3 employees
Auspherix is an Australian early stage anti-infectives company developing novel antibiotics to treat resistant bacterial diseases.
2015
$9.2M
from 2 investors over 2 rounds
Auspherix raised $9.2M on June 3, 2015
Investors: Imperial College London
Auspherix raised $913K on December 3, 2013
Investors: Brandon Capital Partners